Benzinga does not provide investment advice. Shares will likely remain halted until the company issues a press release confirming the results of the FDA panel vote.īenzinga Pro's Top 5 Stocks To Watch For Tues., Nov. EST, results from these panels have historically been heard during the afternoon. While the panel was scheduled to begin at 8 a.m. Trovagene (TROV) - The stock was up about 20% following news a Phase 2 trial of its metastatic prostate cancer treatment showed 72% of patients had decreases in prostate specific antigen levels and 60% completed 3-month treatment.Īmarin (AMRN) - Shares were halted premarket ahead of an FDA Advisory Committee panel for its Vascepa. The stock was up nearly 8% ahead of the opening bell. The company said quarterly advertising sales were down on a year-over-year basis.ĭillard's (DDS) - Reported Q3 EPS of $0.22 on sales of $1.424 billion. 21 hours ago - Benzinga Is Nvidia Stock a Buy Now The stock is cheap right now following a big drop in 2022. The US average for the comfort index is 7.8. SINA (SINA) - Shares were down nearly 10% premarket despite better-than-expected Q3 results. NVIDIA Corporation (NASDAQ: NVDA) was bouncing about 3.5 on Thursday, in tandem with the S&P 500, which was surging almost 2 higher off Wednesday's closing price and almost 5 off Thursday's open. A higher score indicates a more comfortable year-round climate. The company has historically published quarterly results around 4:20 p.m ET. Analysts expect earnings of $1.58 per share on sales of $2.92 billion. NVIDIA (NVDA) - Will report Q3 earnings after the close Thursday. (NASDAQ:NVDA) Why is it moving Shares of several companies in the broader technology sector are lower amid a rise in treasury yields, which has pressured growth stocks. Benzinga Pro's Stocks To Watch For Thursday
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |